ÔçÒÒŮѸÀ×

    1. <form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>
      <address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

      BackGilead Sciences Overview
      Gilead Sciences, Inc.

      Gilead Sciences Target Price

      Analysts' 12-month price predictions for GILD.

      Share Price

      $115.05

      Average Target Price

      $127.0010.4% upside

      5 analysts in the last 4 months

      High: $143 | Low: $108

      Analyst Recommendations

      No recommendations in the last 4 months.

      Revenue & Income Forecast

      Analysts' Target Prices

      DateAnalystPrice TargetCurrent Upside/Downside
      2025-08-11Deutsche BankJames Shin$13517.3% upsideOpen
      2025-08-08Robert W. BairdBrian Skorney$1086.1% downsideOpen
      2025-08-08Morgan StanleyTerence Flynn$14324.3% upsideOpen
      2025-07-14Leerink PartnersDavid Risinger$1140.9% downsideOpen
      2025-06-18Morgan StanleyTerence Flynn$13517.3% upsideOpen
      2025-04-22Cantor FitzgeraldCarter Gould$1258.6% upsideOpen
      2025-03-11Morgan StanleyTerence Flynn$13013% upsideOpen
      2025-03-05Johnson Rice$1269.5% upsideOpen
      2025-03-04Oppenheimer$13214.7% upsideOpen
      2025-01-07RBC CapitalBrian Abrahams$8327.9% downsideOpen
      2024-11-07Piper SandlerJoseph Catanzaro$1058.7% downsideOpen
      2024-10-21BMO CapitalEvan David Seigerman$9418.3% downsideOpen
      2024-10-21Leerink PartnersAndrew Berens$9616.6% downsideOpen
      2024-10-18Morgan StanleyTerence Flynn$8427% downsideOpen
      2024-09-23JefferiesMichael Yee$9517.4% downsideOpen
      2024-09-12Goldman SachsSalveen Richter$7138.3% downsideOpen
      2024-09-12Morgan StanleyTerence Flynn$7931.3% downsideOpen
      2024-09-11Piper SandlerJoseph Catanzaro$9517.4% downsideOpen
      2024-08-14Truist FinancialAsthika Goonewardene$8327.9% downsideOpen
      2024-08-09BMO CapitalEvan David Seigerman$8526.1% downsideOpen
      2024-08-09RBC CapitalBrian Abrahams$7237.4% downsideOpen
      2024-07-08Raymond JamesSteven Seedhouse$9319.2% downsideOpen
      2024-06-24JefferiesMichael Yee$8526.1% downsideOpen
      2024-06-20Robert W. BairdBrian Skorney$8030.5% downsideOpen
      2024-06-17Mizuho SecuritiesSalim Syed$9021.8% downsideOpen
      2024-06-14RBC CapitalBrian Abrahams$7435.7% downsideOpen
      2024-05-20BMO CapitalEvan David Seigerman$8030.5% downsideOpen
      2024-04-24HSBCMorten Herholdt$6940% downsideOpen
      2024-02-14RBC CapitalBrian Abrahams$7633.9% downsideOpen
      2023-09-27RBC CapitalBrian Abrahams$8427% downsideOpen
      2023-09-08Bank of America SecuritiesGeoff Meacham$9517.4% downsideOpen
      2023-02-03Leerink Partners$9120.9% downsideOpen
      2023-02-03Piper Sandler$1122.7% downsideOpen
      2023-01-03Wells Fargo$9021.8% downsideOpen
      2022-12-01Morgan Stanley$8129.6% downsideOpen
      2022-10-31BarclaysCarter Gould$7633.9% downsideOpen
      2022-10-28Truist FinancialRobyn Karnauskas$9120.9% downsideOpen
      2022-10-28Robert W. BairdBrian Skorney$6940% downsideOpen
      2022-09-15Truist Financial$7633.9% downsideOpen
      2022-09-13Wells Fargo$7435.7% downsideOpen
      2022-07-15Morgan Stanley$6543.5% downsideOpen
      2022-05-23Leerink PartnersDavid Risinger$6840.9% downsideOpen
      2022-05-17Piper SandlerDo Kim$6940% downsideOpen
      2022-04-29BMO Capital$6345.2% downsideOpen
      2022-04-29Piper Sandler$7336.5% downsideOpen
      2022-04-06Piper SandlerDo Kim$7138.3% downsideOpen
      2022-03-31Wells FargoMohit Bansal$6345.2% downsideOpen
      2022-03-01JefferiesMichael Yee$8030.5% downsideOpen
      2022-02-24Morgan StanleyMatthew Harrison$6940% downsideOpen
      2022-02-24UBSColin Bristow$5453.1% downsideOpen
      HoMEÔçÒÒŮѸÀ×